Work

Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG)

Year: 2021

Type: article

Abstract: Long-term survival in Diffuse Intrinsic Pontine Glioma (DIPG) is very rare. The purpose of this report is to detail the early (1988) use of IV Antineoplaston therapy (ANP {A-10 + AS2-1}) and its efficacy in DIPG while presenting the 27.7-year survival of a 36-year-old patient treated with ANP for progressive DIPG.

Source: International Journal of Radiology and Imaging Technology

DOI: 10.23937/2572-3235.1510073

Authors: Burzynski Stanislaw R, Janicki Tomasz, Burzynski Gregory S, Beenken Samuel

Institutions: Burzynski Research Institute, University of California, San Francisco, Calera (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: National Institutes of Health